Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Longo

Showing results (71-80 of 484) with videos related to

Pageof 49
Sort By:
The American Journal of Medicine|October 1, 1981
Peripheral destruction of platelets in chronic lymphocytic leukemia: recognition, prognosis and therapeutic implicationsD B Rubinstein, D L Longo
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1988
Adoptive cellular therapyW J Urba, D L Longo
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1987
LymphomasD L Longo, V T Devita
Important Advances in Oncology|January 11, 1992
The use of combination chemotherapy in the treatment of early stage Hodgkin's diseaseD L Longo, V T DeVita
Lancet (London, England)|August 18, 1979
Cosmetic talc and ovarian cancerD L Longo, R C Young
Investigative Radiology|September 1, 1993
Hodgkin's disease in adults. Part IIW J Urba, D L Longo
Pathology and Immunopathology Research|January 1, 1988
Adoptive therapies: quo vadis?J W Clark, D L Longo
Current Treatment Options in Oncology|June 12, 2002
T-small cell disordersE H Westin, D L Longo
Comprehensive Therapy|January 1, 1983
Ovarian cancer: epidemiology, diagnosis, and managementD W Blayney, D L Longo
Neurology|February 1, 1980
Focal neurologic symptoms in hypercalcemiaD L Longo, J M Witherspoon
Pageof 49

Showing results (71-80 of 484) with videos related to

Sort By:
Pageof 49
The American Journal of Medicine|October 1, 1981
Peripheral destruction of platelets in chronic lymphocytic leukemia: recognition, prognosis and therapeutic implicationsD B Rubinstein, D L Longo
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1988
Adoptive cellular therapyW J Urba, D L Longo
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1987
LymphomasD L Longo, V T Devita
Important Advances in Oncology|January 11, 1992
The use of combination chemotherapy in the treatment of early stage Hodgkin's diseaseD L Longo, V T DeVita
Lancet (London, England)|August 18, 1979
Cosmetic talc and ovarian cancerD L Longo, R C Young
Investigative Radiology|September 1, 1993
Hodgkin's disease in adults. Part IIW J Urba, D L Longo
Pathology and Immunopathology Research|January 1, 1988
Adoptive therapies: quo vadis?J W Clark, D L Longo
Current Treatment Options in Oncology|June 12, 2002
T-small cell disordersE H Westin, D L Longo
Comprehensive Therapy|January 1, 1983
Ovarian cancer: epidemiology, diagnosis, and managementD W Blayney, D L Longo
Neurology|February 1, 1980
Focal neurologic symptoms in hypercalcemiaD L Longo, J M Witherspoon
Pageof 49